Ph.D Studentship at Centre of Bio-Medical Research | 10 posts
Centre of Bio-Medical Research (CBMR) is committed to build a world class research institute dedicated to disease-oriented-research and to translate discoveries and observations of the laboratory into new diagnosis and therapies for the benefit of humanity. Research at CBMR emphasizes the creation of (basic) knowledge in the chemical and biosciences for its application in diagnosis and therapies, the pursuit of fundamental scientific advances through interdisciplinary programs and collaborations, and the education and training of researchers preparing to meet the biomedical challenges of the future. The mission of CBMR is to establish itself as a new research platform that develops and create an interdisciplinary environment of biomedical research and its applications contributing to the development of both diagnostics and medicine.
Post : Ph.D Studentship
Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation. Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.
Conceives experimental strategies and leads and participates in the design and conduct of experiments in biological systems to characterize and validate novel targets and test efficacy of potential therapeutics to prioritize them for further development in a variety of disease areas. Possesses knowledge of relevant experimental biology techniques, possibly including: molecular biology techniques, in vitro binding, biochemical and cell- based assays, cell culture, pharmacologic dosing, disease model testing, PK and metabolism methodologies. Participates in technology development in the area of in vitro assays, cell biology or in vivo testing. Interprets, communicates experimental findings and documents according to approved Nektar policy. Maintains broad knowledge of state-of-the-art principles and theories, and develops and analyzes new product concepts by reviewing preclinical and clinical literature. May lead discovery teams, as necessary. Mentors and guides junior scientists and may manage research associates. This position contributes to and supports the company’s research and development efforts to create high value therapeutics to address unmet medical needs.
Merck Limited (formerly E. Merck Limited) was set up in India as the first Merck subsidiary in Asia in 1967. The Company operates both its Pharmaceuticals and Chemicals businesses in the country.
The role and responsibility of Commissioner of Health & Family Welfare is implementation of Maternal and Child Health Care and Family Welfare services in the State viz. Family Planning, Antenatal Care, Postnatal Care including Immunization services. The focus is mainly on promotive and preventive care. Family Welfare Programme is a Centrally Sponsored Programme with 100% financial assistance from Govt. of India from Ministry of Health & Family Welfare. Certain schemes are also assisted by State Government. External aided agencies are also assisting for the activities under National Rural Health Mission.
Generated with passion to serve health and quality solutions. Admac Lifesciences, a part of Admac Group Of Companies is a specialty pharmaceutical company dedicated to Oncology, engaged in the development, manufacture and commercialization of pharmaceutical products at affordable prices. We, at Admac Lifesciences aim to facilitate hospitals and other healthcare organizations to maximize their potential with our innovative quality healthcare products. We provide a wide array of customized solutions right from conceptualization, to planning , designing, to project management of hospitals with optimal operationalisation and clientele satisfaction.
The genesis of the ISHITA group in 1972 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad. Buoyed by the growth of its first Venture, the group made its maiden foray in the pharma sector in 1981 by setting up a small Bulk drugs plant at Surendranagar in the state of Gujarat, to cater to the need of Pharma industry for Quality Products. The Bulk Drugs Industry at that point of time was highly dependent on costly imports and the growth was not easily achievable. But ‘ISHITA’ continued to achieve excellence in Quality of its products using innovative technology, and cost effective processes developed by in house R&D.Manufacturer of various Active Pharma Ingredients (bulk actives and their salts), drug intermediates, excipients and fine chemicals.
